Fundraising Fox
/People
Sign in

Ran Nussbaum

InvestorFounder

Managing Partner & Co-Founder at Pontifax Venture Capital · Managing Partner & Co-founder at Pontifax

Israel

Writes $10M – $50M checks · typically $25M

FoundedPontifax

Find your path to Ran

Sign up to see every warm intro you have to Ran

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Ran. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Managing partner and co-founder of The Pontifax Group. Has served on boards of numerous biotech companies including Kite Pharma, cCAM Therapeutics, ArQule, Emergence, and Prevail, and currently chairs Graviton, Lutris Pharma, and Adcytherix.

Contact· self-published, not guessed

Managing Partner & Co-founder at Pontifax

Intro paths

→

In turn, Ran can intro founders to Pontifax's investors below.

Pontifax's investors · 6

2B.VCTel-AvivBits x BitesShanghai · since 2018Emerald Technology Ventures AgZurich · $540K – $5.4M checks · since 2018Five Seasons VenturesParis · $2.2M – $10.8M checks · since 2018Pontifax AgTechLos Angeles · since 2018Tekfen VenturesNew York · $1M – $3M checks · since 2018

Co-founders at Pontifax

TKTomer Kariv
Tomer KarivCo-founder & Chief Executive Officer

Investments

Sources: SEC Form D filings · curated public sources.

Colleagues at Pontifax Venture Capital

Asaf Shinar
Director at Pontifax Venture Capital
Lina Kaminski
Principal at Pontifax Venture Capital
Momi Karako
Investment Professional at Pontifax Venture Capital
Ohad Hammer
Investment Professional at Pontifax Venture Capital
Pat McClain
Principal, Financial Performance at Five Elms Capital
Tomer Kariv
Chief Executive Officer at Pontifax Venture Capital

Frequently asked questions

Who is Ran Nussbaum?
Managing partner and co-founder of The Pontifax Group. Has served on boards of numerous biotech companies including Kite Pharma, cCAM Therapeutics, ArQule, Emergence, and Prevail, and currently chairs Graviton, Lutris Pharma, and Adcytherix.
Where does Ran Nussbaum work?
Ran Nussbaum is Managing Partner & Co-founder of Pontifax and Managing Partner & Co-Founder at Pontifax Venture Capital.
What check size does Ran Nussbaum write?
Ran Nussbaum typically writes checks of $10M – $50M.
What companies did Ran Nussbaum found?
Ran Nussbaum founded Pontifax.
What boards does Ran Nussbaum sit on?
Ran Nussbaum holds tracked board seats at Graviton Bioscience, LB Pharmaceuticals, Urogen.
What companies has Ran Nussbaum invested in?
Investments tracked here include Adcytherix, Arqule, Fore Biotherapeutics, Graviton Bioscience, Kamari Pharma, Keros Therapeutics, LB Pharmaceuticals.

Founder mafias

Kite Pharma mafia2

Also came through, then founded or led a company.

Peter EmtageGlobal Head of Cell Therapy ResearchFounded Santa Ana Bio

Urogen mafia2

Also came through, then founded or led a company.

Jim RobinsonMember Board of DirectorsFounded A2 Biotherapeutics

About this profile. Compiled from public sources — Pontifax Venture Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights